IOL Chemicals & Pharmaceuticals Downgraded to 'Sell' by MarketsMOJO Due to Poor Long-Term Growth and Negative Financial Results

Aug 22 2024 06:39 PM IST
share
Share Via
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMojo due to its poor long-term growth and negative financial results. Despite a low debt to equity ratio and fair valuation, the company's stock has underperformed the market and its profits have fallen. Investors should carefully consider all factors before investing.
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has recently been downgraded to a 'Sell' by MarketsMOJO on August 22, 2024. This decision was based on the company's poor long-term growth, as its operating profit has only grown at an annual rate of 15.09% over the last 5 years.

In addition, the company's recent financial results for the quarter ending June 24 have also been negative. Its net sales were at a low of Rs 502.38 crore, while its PBT LESS OI (profit before tax less other income) has fallen by -15.2% and its PAT (profit after tax) has fallen by -10.8%.

Despite being a smallcap company, IOL Chemicals & Pharmaceuticals has a low debt to equity ratio of 0.10 times. However, it is concerning that domestic mutual funds hold only 0.17% of the company. This could indicate that they are not comfortable with the company's current price or its business.

Moreover, the stock has underperformed the market in the last 1 year, generating a return of only 25.61% compared to the market's return of 37.99% (BSE 500). However, the technical trend for the stock has recently improved from Mildly Bearish to Mildly Bullish, with a return of 7.46% since August 20, 2024. Multiple factors such as MACD, Bollinger Band, KST, and OBV are currently bullish for the stock.

With a ROE (return on equity) of 8.3, the stock is currently fairly valued with a price to book value of 1.7. It is also trading at a discount compared to its average historical valuations. However, it is important to note that while the stock has generated a return of 25.61% in the past year, its profits have fallen by -21.4%.

In conclusion, while IOL Chemicals & Pharmaceuticals may seem like an attractive investment due to its low debt and fair valuation, its poor long-term growth and negative financial results may be a cause for concern. Investors should carefully consider all factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News